Joseph T Hull, PhD
Supernus Pharmaceuticals, Inc. · Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Joseph T Hull, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:35 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT06185985 · Open-label Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD and Mood SymptomsSupernus Pharmaceuticals, Inc. · completed · Attention-Deficit/Hyperactivity Disorder · study director
- Ph2/Ph3NCT04815967 · Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb SpasticitySolstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC · terminated · Spasticity, Cerebrovascular Accident, Multiple Sclerosis · study director
- Ph2/Ph3NCT04099667 · Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Lower Limb SpasticitySolstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC · terminated · Spasticity · study director
- Ph2NCT02633527 · Efficacy and Safety of SPN-812 (Viloxazine Extended-release Capsule) in Children With ADHDSupernus Pharmaceuticals, Inc. · completed · Attention-Deficit/Hyperactivity Disorder (ADHD) · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:35 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.